The first legitimate consumer peptide brand.
For years, the peptide industry has been fragmented between clinical injections requiring cold-chain logistics and ineffective oral supplements destroyed by the gastrointestinal tract. VERO was founded to bridge this gap, bringing clinical-grade peptide protocols directly to consumers without the clinic or the needle.
Engineering the
VERISORB™ Matrix.
The fundamental flaw with traditional oral peptides is first-pass metabolism. The stomach's low pH and digestive enzymes completely denature peptide chains before they can reach systemic circulation.
Our formulation team spent three years developing VERISORB™—a dual-action protection system. First, the peptide payload is encapsulated in a lipid bilayer (liposomal delivery). Second, we utilize rapid-dissolve sublingual technology to bypass the GI tract entirely, transferring the payload directly across the mucosal membrane and into the bloodstream.
